References
- Jung M, Notario V, Dritschilo A. Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Res 1992; 52: 6390–3
- Brachman D G, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 1993; 53: 3667–9
- Lee J M, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 1993; 90: 5742–6
- Clarke A R, Purdie C A, Harrison D J, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849–52
- Biard D SF, Martin M, Le Rhun Y, et al. Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res 1994; 54: 3361–4
- Lowe S W, Bodis S, McClathey A, et al. P53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807–10
- McLlwrath A J, Vasey P A, Ross G M, Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 1994; 54: 3718–22
- Merritt A J, Potten C S, Kemp C J, et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994; 54: 614–7
- Wattel E, Preudhomme C, Hecquet B, et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 1994; 84: 3148–57
- Servomaa K, Kiuru A, Grénman R, Pekkola-Heino K, Pulkkinen J O, Rytömaa T. P53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines., Submitted
- Grénman R, Pekkola-Heino K, Joensuu H, Aitasalo K, Klempi P, Lakkala T. UT-MUC-1, a new muco-epidermoid carcinoma cell line and its radiosensitivity. Arch Otolaryngol Head Neck Surg 1992; 118: 542–7
- Pekkola-Heino K, Kulmala J, Klemi P, et al. Effects of radiation fractionation on four squamous cell carcinoma cell lines with dissimilar inherent radiation sensitivity. J Cancer Res Clin Oncol 1991; 117: 597–602
- Pekkola-Heino K, Joensuu H, Klemi P, Grénman R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous cell carcinoma cell lines. Arch Otolaryngol Head Neck Surg 1994; 120: 750–4
- Grénman R, Burk D, Virolainen E, et al. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 1989; 44: 131–6
- Fertil B, Detinger H, Courdi A, Malaise P. Mean inac tivation dose a useful concept for intercomparison of human cell survival curves. Radiat Res 1984; 99: 73–84
- Finnish Cancer Registry 1993
- Peters LJ. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother Oncol 1990; 17: 177–90
- Weichselbaum R R, Rotmensch J, Ahmed-Swan S, Beckett MA. Radiobiological characterization of 53 human tumor cell lines. Int J Radiat Biol 1989; 56: 553–60
- Grénman R, Carey T E, McClatchey K D, et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 1991; 67: 2741–7
- Pekkola-Heino K. Radiation response of squamous cell carcinoma. in vitro studies with cell lines in a 96-well plate clonogenic assay. Academic dissertation., Turku 1992
- Kastan M B, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304–11
- Lane DP. p53, quardian of the genome. Nature 1992; 358: 15–6
- Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994; 370: 220–3
- Smith M L, Chen I-T, Zhan Q, O'Connor P M, Fornace AJ. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995; 10: 1053–9
- Xia F, Wang X, Wang Y-H, et al. Altered p53 status correlates with dfferences in sensitivity to radiation-induced muta tion and apoptosis in two closely related human lympho blast lines. Cancer Res 1995; 55: 12–5